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Abstract
Background: Dynactin subunit 1 is the largest subunit of the dynactin complex, an activator of the molecular
motor protein complex dynein. Reduced levels of DCTN1 mRNA and protein have been found in sporadic
amyotrophic lateral sclerosis (ALS) patients, and mutations have been associated with disease, but the role of this
protein in disease pathogenesis is still unknown.
Methods: We characterized a Dynactin1a depletion model in the zebrafish embryo and combined in vivo molecular
analysis of primary motor neuron development with live in vivo axonal transport assays in single cells to investigate
ALS-related defects. To probe neuromuscular junction (NMJ) function and organization we performed paired motor
neuron-muscle electrophysiological recordings and GCaMP calcium imaging in live, intact larvae, and the synapse
structure was investigated by electron microscopy.
Results: Here we show that Dynactin1a depletion is sufficient to induce defects in the development of spinal cord
motor neurons and in the function of the NMJ. We observe synapse instability, impaired growth of primary motor
neurons, and higher failure rates of action potentials at the NMJ. In addition, the embryos display locomotion defects
consistent with NMJ dysfunction. Rescue of the observed phenotype by overexpression of wild-type human DCTN1-
GFP indicates a cell-autonomous mechanism. Synaptic accumulation of DCTN1-GFP, as well as ultrastructural analysis of
NMJ synapses exhibiting wider synaptic clefts, support a local role for Dynactin1a in synaptic function. Furthermore, live
in vivo analysis of axonal transport and cytoskeleton dynamics in primary motor neurons show that the phenotype
reported here is independent of modulation of these processes.
Conclusions: Our study reveals a novel role for Dynactin1 in ALS pathogenesis, where it acts cell-autonomously to
promote motor neuron synapse stability independently of dynein-mediated axonal transport.
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Background
ALS is an adult-onset, neurodegenerative disease affect-
ing upper and lower motor neurons. It leads to denerv-
ation at the neuromuscular junction, muscle wasting
and progressive paralysis, ending in the demise of the
patient two to 5 years after diagnosis. Many causative
mutations and risk factors have been identified in the
last few decades targeting genes like SOD1, TARDBP
and FUS, and more recently, C9ORF72, along with mul-
tiple pathogenic mechanisms, including protein misfold-
ing and aggregation, impaired RNA metabolism and
excitotoxicity (reviewed here [1–5]). Recent evidence
revealed multiple cases where an inheritance of risk vari-
ants in multiple genes led to disease or altered pene-
trance of pathogenic mutations. Considering the
sporadic nature of most cases, this proposed oligogenic
etiology of ALS [4, 6–8] highlights the importance of
studies focused on rare variants. Indeed, as ALS remains
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a disease of heterogeneous clinical presentation and vari-
able progression, diagnosed on exclusion, insights into
pathophysiological processes could help categorization
and lead to the elaboration of effective treatment target-
ing specific mechanisms.
Axonal transport defects is a common mechanism that
has been observed in many neurodegenerative diseases,
including ALS [9–11]. Indeed, defects in both fast and
slow axonal transport have been reported for cargoes such
as mitochondria, endosomes and vesicles containing
trophic signaling receptors like TrkB [12–16]. As motor
neurons extend long projections to reach their target, they
are particularly dependent on axonal transport for com-
munication between the synapse and the cell body, to sup-
ply the synapse with building components and to remove
cellular detritus for degradation. Axonal transport is medi-
ated by ATP-driven molecular motors, which carry
vesicles and organelles by moving along the microtubule
network. This component of the cell cytoskeleton is
composed of protofilaments polymerized from tubulin
subunits which are oriented in a highly polarized manner
in the axon, resulting in a fast-growing end (+) at the syn-
apse and a slow-growing end (−) oriented toward the nu-
cleus at the soma. The dynein motor complex transports
cargo in the retrograde direction (− end directed) [17] and
relies on multi-subunit complexes like dynactin for func-
tional versatility [18, 19].
Dynactin subunit 1 (DCTN1, ENSG00000204843;
OMIM 601143, hereafter referred to as Dynactin1) is the
largest subunit of the dynactin complex and acts as the
link between this macromolecular complex and the mi-
crotubules via its CAP-Gly domain [20, 21]. The dynac-
tin complex regulates the activity of molecular motor
complex dynein, where Dynactin1 serves as the link
between both complexes [20, 22], and orchestrates the
motor’s recruitment to the microtubule network at distal
ends [20, 23]. It has therefore been thought to be essen-
tial for dynein function, and for axonal transport [24].
DCTN1 was found to be down regulated in sporadic
ALS patients, resulting in a lower protein expression
[25, 26], suggesting altered expression of this protein
could be involved in the pathophysiological process.
Mutations in DCTN1 have also been reported in ALS
patients [8, 27–31], however their role in motor neuron
degeneration is not clear. Indeed, mutations in this gene
have previously been found in patients affected with
Perry Syndrome, a disease characterized by Parkinson-
ism. In this case, the reported mutations affect the the
N-terminal CAP-Gly domain (G59S) interfere with the
incorporation of this subunit within the dynactin com-
plex and leads to the formation of misfolded protein ag-
gregates in a phenotype similar to what is observed
following the loss of the whole CAP-Gly domain [32,
33]. In contrast, the mutations reported in ALS cases
don’t target a particular domain (for instance T1249I,
M571 T, R785W, R1101K [28], I196V and R1049Q [30])
and have been found to lead to proper incorporation of
Dynactin1 within the dynactin complex without aggre-
gate formation (for M571 T, R785W, R1101K and
T1249I [34]). Because of its known function in regulat-
ing dynein activity and because axonal transport deficits
are a feature of ALS, Dynactin1’s implication in neurode-
generation has been assumed to involve axonal transport
dysregulation [5, 35].
Here, we analyze the effect of Dynactin1 depletion in
the zebrafish embryo (genetic inactivation ofortholog
dynactin1a ENSDARG00000019743; mutant line
mokm632) on the development of the caudal primary
(CaP) motor neurons of the spinal cord. Homozygous
mutant embryos, referred to as mok m632−/− hereafter,
initially extend normal CaPs and establish proper neuro-
muscular junctions (NMJ) with fast-twitch muscle fibers.
Depletion of Dynactin1a leads to synapse instability,
which impairs further growth and causes electrophysio-
logical dysfunction and locomotor deficits. These defects
were found to be independent of changes in axonal
transport dynamics or cytoskeletal modulation, two
well-known functions relying on Dynactin1. Our results
point to a local role for this protein in synapse stability
where a protein depletion could contribute to the oligo-
genic etiology of ALS pathogenesis by inducing NMJ
dysfunction without leading to ALS-related motor
neuron degeneration in itself.
Material and methods
Zebrafish husbandry and transgenic lines
Zebrafish lines were housed in the Curie Institute animal
facility, maintained at 28,5 °C and embryos were raised
in egg medium containing methylene blue. All experi-
ments were performed according to the French and
European Union animal welfare guidelines, as well as
the Curie Institute ethics protocol.
The following transgenic and mutant fish lines were used:
Tg(mnx1:Gal4) [36]; mok m632(dctn1am632/m632) [37–39];






Fusion proteins were generated by fusing rab5c, and
rab7 open reading frames from p3’E vectors (kindly pro-
vided by Brian Link [42]) with eGFP into pME (Tol2Kit)
[43]. UAS constructs were assembled by combining
pME-rab-GFP, p3’E-SV40 and a p5′E-4nrUAS-tagRFP-
Caax-pA-4nrUAS vector (containing a membrane-
bound tagRFP reporter under the expression of four
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non-repeated UAS sequences) [44] into a pDestTol2CG
#393 destination vector [43] using the MultiSite Gateway
Three-Fragment Vector Construction Kit (ThermoFisher
Scientific). The rab11a cDNA was amplified from zebra-
fish total cDNA using primers 5’E- atggggacacgagacgacg
and 5′- ctagatgctctggcagcactg and cloned into a
pDONRP2R-P3 to generate a p3’E vector, which was
combined with a pME-eGFP vector and a p5’-4nrUAS-
tagRFPCaax-pA-4nrUAS vector into a pDestTol2CG
#393 destination vector [43] using the MultiSite Gateway
Three-Fragment Vector Construction Kit (ThermoFisher
Scientific).
mnx1:lyn-GFP-pA
A p5’E entry vector was generated by PCR amplification
of a 125 bp promoter fragment of the mnx1 gene [36]
followed by a BP reaction. The middle entry plasmid
was obtained by BP reaction from amplification of two
consecutive copies of a sequence encoding the Palm-
myr signal of Lyn kinase from Mus musculus
(MGCIKSKRKDNLNDDE). The construct was assem-
bled into a pDONR221 using the MultiSite Gateway
Three-Fragment Vector Construction Kit (ThermoFisher
Scientific) to obtain mnx1:lyn-eGFP-pA.
pUAS-dendra2-rab3-pA
A middle entry vector carrying dendra2-rab3 was gener-
ated by fusing the rab3 open reading frame of pBHUAS-
Rab3-YFP (kindly provided by Michael Nonet) [45], and
the dendra2 sequence from pDendra2-N1 (kindly pro-
vided by Jean-René Huynh, Institut Curie, Paris) via PCR
amplification. The middle entry vector was combined
with a standard p5’UAS vector (Tol2kit) and a standard
p3’SV40pA using the MultiSite Gateway Three-Fragment
Vector Construction Kit (ThermoFisher Scientific) to
obtain pUAS-dendra2-rab3-pApUAS-dendra2-rab3-pA.
pUAS-EB3-meGFP-pA
The pME-EB3 plasmid [41] was combined with
p3’meGFP under a UAS promoter and assembled into
pDONR221 using the MultiSite Gateway Three-
Fragment Vector Construction Kit (ThermoFisher Scien-
tific) to obtain pUAS-EB3-GFP.
14xUAS:ubc-EB3-meGFP-E2A-tagRFP-rab3-pA
This construct was obtained via Gibson assembly using
the pT1UciMP Tol1 destination vector previously
described. The EB3-meGFP fragment was amplified via
PCR from pUAS-EB3-meGFP-pA, the E2A-tagRFP was
amplified via PCR from 4nrUAS-tagRFPCaax-pA-
4nrUAS-eGFP-Rab5c-pA, and the rab3-pA was amplified
via PCR from pUAS-dendra2-rab3-pA. All fragments
were inserted after the ubc intron of the pT1UciMP Tol1
destination vector opened by restriction digest with
NcoI-HF (NEB) to obtain 14xUAS:ubc-EB3-meGFP-
E2A-tagRFP-rab3-pA.
14xUAS:ubc-hDCTN1-eGFP-E2A-tagRFPCaax-pA
This construct was obtained via Gibson assembly using
the pT1UciMP Tol1 destination vector previously de-
scribed. Dynactin1 was amplified via PCR from a
pCDNA3.1 vector containing human Dynactin1-GFP
(kindly provided by Stefan Liebau [30]) and fused to
eGFP and E2A-tagRFPCaax (described above) using the
NEBuilder HiFi DNA Assembly Cloning Kit (NEB).
These three sequences were inserted after the ubc intron
of the pT1UciMP Tol1 destination vector opened by re-
striction digest with NcoI-HF (NEB) to obtain 14xUAS:
ubc-hDCTN1-eGFP-E2A-tagRFPCaax-pA.
14xUAS:ubc-ngfra-eGFP-E2A-tagRFPCaax-pA
Similar to the construct above, the cDNA sequence of
the ngfra zebrafish gene (ENSDARG00000088708) cod-
ing for the p75 trophic receptor was amplified from zeb-
rafish cDNA via PCR and combined with eGFP and
E2A-tagRFPCaax into the pT1UciMP Tol1 destination
vector using the NEBuilder HiFi DNA Assembly Cloning
Kit (NEB) to obtain 14xUAS:ubc-ngfra-eGFP-E2A-
tagRFPCaax-pA.
RNA synthesis
RNA for human Dynactin1-GFP was synthesized from
the pCDNA3.1 construct described previously (kindly
provided by Stefan Liebau [30]) using the mMESSAGE
mMACHINE T7 transcription kit (Invitrogen).
Microinjections
Embryos were injected at the zygote stage (1 cell) using
a Picospritzer III pressure ejector and a glass capillary
tube pulled with a Flaming-Brown puller as a needle. In-
jection mixes contained phenol red to judge injected vol-
ume and were set to 400 ng/ul of RNA, and 30-50 ng/ul
of recombinant DNA with or without added transposase
mRNA (50 ng/ul).
Whole-mount immunohistochemistry
Embryos were fixed in 4% paraformaldehyde diluted in
PBS for 4 h at room temperature. They were then rinsed
multiple times in PBS containing 0,1% triton X-100
(PBST) then incubated with a solution of 1 mg/ml of
collagenase (from Clostridium histolyticum, Sigma) in
PBS for 20 min (2dpf embryos) or 2 h (6dpf embryos).
The embryos were rinsed several times with PBST then
blocked for 1 h in a block solution containing 1% bovine
serum albumin (BSA), 2% normal goat serum, 1%
DMSO and 0,1% triton X-100. The primary antibody
was then added with fresh block solution according to
the working dilutions listed below, with an incubation
Bercier et al. Molecular Neurodegeneration           (2019) 14:27 Page 3 of 22
time of 2 h at room temperature. After several washes in
PBST, the secondary antibody was added in fresh block
solution for an incubation of 2 h at room temperature,
then rinsed thoroughly. The embryos were then proc-
essed for imaging.
For labelling with conjugated α-bungarotoxin, the fix-
ation step was done overnight and the block solution
used was composed of 2% BSA, 0,5% triton X-100 in
PBS. The incubation time for the conjugated α-
bungarotoxin was 30 min at room temperature.
List of antibodies
 Anti-synaptotagmin2 (znp1) (Developmental Studies
Hybridoma Bank), monoclonal mouse IgG2a, used
at 1:300.
 Conjugated α-bungarotoxin-AlexaFluor 594 (Ther-
moFischer Scientific), α-subunit of the nicotinic
acetylcholine receptor (AChR) extracted from Bun-
garus multicinctus venom and conjugated with Alexa
Fluor 594 used at 10μg/ml.
 Anti-acetylated tubulin clone 6–11-B-1 (Sigma)
purified mouse monoclonal IgG antibody 1,5 mg/ml
used at 1:200.
 Anti-GFP (GeneTex, Euromedex) purified chicken
polyclonal IgG antibody, 10mg1ml, used at 1:300.
 Goat anti-chicken Alexa Fluor 488 (Life Technolo-
gies) purified goat antibody, used at 1:1000
 Goat anti-mouse Alexa Fluor 488 (Life Technolo-
gies) purified goat antibody, used at 1:1000
 Goat anti-mouse Alexa Fluor 635 (Life Technolo-
gies) purified goat antibody, used at 1:1000
Touch-evoked escape response assay
2dpf embryos were dechorionated and left to acclimate at
room temperature 30min prior to the experiment. Each
embryo was placed in the center of a 144mm petri dish
containing egg medium. A refractory period of 30 s was
observed before the presentation of a stimulus. The escape
response was elicited by a light brush on the tail of the
embryo with a pair of blunt forceps and was recorded with
an Olympus FE-5000 camera or with a Sony HDR-AS50
at 30Hz. The videos were analyzed in ImageJ using the
Manual Tracking plugin (Fabrice Cordelières, Institut
Curie-Orsay, France).
Morphological images
Images of the embryos were acquired with a Leica MZ
FLIII stereomicroscope (Leica) equipped with a Leica
DFC310FX digital camera (Leica).
Fluorescence microscopy for RNA injection validation
Images of the GFP signal in the 488 nm wavelength
channel was acquired on a Leica DM 3000 LED
microscope equipped with a DMK 33UX250 USB3.0
monochrome industrial camera (The Imaging Source,
Bremen, Germany) using Lucia 4.60 software (Labora-
tory Imaging, Prague, Czech Republic).
Spinning disk confocal microscopy for cell morphology
and time-lapse imaging
We limited our study to CaP motor neurons within a 4-
somite window around the cloaca in order to avoid mor-
phological and functional variability that arise between
cell types and along the rostro-caudal developmental
wave.
Imaging was performed on a Roper confocal spinning
disk head mounted on a Zeiss upright microscope, and
acquisitions were done with a CoolSNAP HQ2 CDD
camera (Photometrics, USA) through the MetaMorph
software (Molecular Devices, USA). Embryos were anes-
thetized using 0.02% tricaine (MS-222, Sigma) diluted in
egg water and embedded in 1% low melting-point agar-
ose in a glass-bottom cell tissue culture dish (Fluorodish,
World Precision Instruments, USA). Acquisitions were
done using water immersion long working distance
lenses, at 40x magnification (W DIC PL APO VIS-IR;
421,462–9900) for z-stack images of the whole tectum
and at 63x magnification (W PL APO VIS-IR (421480–
9900) for single plane time-lapse imaging of linear
axonal segments, and for filopodia imaging. Acquisitions
were done using the Metamorph software (Molecular
Devices) and resolution in z was set at 1um for stacks.
Images were assembled and analyzed in ImageJ (NIH).
6dpf z- stacks taken in two frames were stitched to-
gether using the pairwise stitching function of the
Stitching plugin [46].
Time-lapse imaging
Live imaging of axonal transport was done using fusion
proteins combined with a membrane reporter, described
previously, expressed in the CaP primary motor neurons
by use of the Tg(mnx1:GAL4) line. Time-lapse parame-
ters were determined based on the speed of transport in
the spinal cord and set at 1 s intervals for mitochondria
(4nrUAS:tagRFPCaax-pA-4nrUAS:PhbGFP-pA-Tol2;
cmcl2:eGFP), for 10 min total duration, and set at 500
ms for endosomes (rab5c, 7 and 11a), p75, and eb3
comets for 5 min total duration. For filopodia dynamics
time-lapses, z-stacks were taken every 2 min for 10 min
of total duration.
Kymogram production and analysis
Time-lapse images were assembled and analyzed in Ima-
geJ. Kymograms were extracted for each time-lapse serie
on linear axonal segments using the Kymograph Tool
(Montpellier RIO Imaging, CNRS, France), where each
Bercier et al. Molecular Neurodegeneration           (2019) 14:27 Page 4 of 22
pixel on the Y axis represents one timepoint projected
against axonal length (X axis).
Calcium imaging during fictive locomotion
4dpf Tg(mnx1:gal4; UAS:GCaMP5G) double transgenic
larvae were screened for dense labeling and good expres-
sion of GCaMP5 in spinal motor neurons under a dissect-
ing microscope equipped with an epifluorescence lamp
(Leica, Wetzlar, Germany). Larvae were anaesthetized in
0.02% Tricaine-Methiodide (MS-222, Sigma-Aldrich)
diluted in fish facility water and mounted on their lateral
side in 1.5% low-melting point agarose in glass-bottom
dishes filled with external solution ([NaCl] = 134mM,
[KCl] = 2.9mM, [MgCl2] = 1.2mM, [HEPES] = 10mM,
[glucose] = 10mM and [CaCl2] = 2.1mM; adjusted to pH
7.7–7.8 with NaOH and osmolarity 290mOsm). Larvae
were immobilized by injecting 0.1–0.3 nL of 0.5 mM
alpha-Bungarotoxin (Tocris, Bristol, UK) in the ventral
axial musculature. Zebrafish larvae were imaged using a
custom spinning disk microscope (3i, Intelligent Imaging
Innovations, Denver, CO, USA) equipped with a set of
water-immersion objectives (Zeiss 20X, 40X, NA= 1). Re-
cordings were acquired using Slidebook software at 10Hz
with a 488 nm laser. Gain and binning were manually op-
timized to maximize signal to noise ratio. Z-projection
stacks showed full pattern of expression using Fiji (Schin-
delin et al.,2012). Thin-walled, borosilicate glass capillaries
(Sutter Instruments, Novato, CA, USA) were pulled and
fire-polished from a Flaming/Brown pipette puller (Sutter
Instruments, Novato) to generate water jet stimulation pi-
pettes. Stimulation pipettes were filled with external solu-
tion, connected to a pneumatic microinjector with
vacuum pressure (WPI, Sarasota, USA), and positioned
next to the preparation using motorized micromanipula-
tors under the microscope. Water jet stimulations were ei-
ther manually induced, or timed online in pClamp8.2
(Axon instruments). Stimulations were elicited every 2–3
min to reduce habituation. Positions of cells along the D-
V axis were computed using Fiji and Matlab (Mathworks,
USA). Calcium signals were extracted online using custom
MATLAB scripts (Kevin Fidelin, Wyart Laboratory, Paris).
Regions of interest (ROIs) were manually designed and
raw fluorescence signals time series were extracted as the
mean fluorescence from individual ROIs at each time
point of the recording. DF/F calcium traces were gener-
ated and aligned to water jet stimuli in Matlab.
In vivo intracellular recordings
6dpf zebrafish larvae were decapitated and pinned to a
Sylgard coated recording chamber (Sylgard 184, Dow
Corning, Midland, MI, USA) through the notochord
with electrolytically sharpened tungsten pins. The skin
was removed and the specimen was bathed briefly in a
10% formamide solution and subsequently washed in
bath recording solution to eliminate spontaneous muscle
twitching. For paired recordings, the dura was exposed
by suctioning away dorsal muscle fibers with a glass pip-
ette. Typically 3–7 segments of dorsal muscle were
removed. Recording electrodes were fashioned from
capillary glass (1.5 mm O.D., 1.1 ID, WPI, Sarasota, FL,
USA) with a horizontal puller (P1000, Sutter Instru-
ments, Novato, CA). Electrode resistances were 8–14
MΩ for CaP motor neurons and 2–5MΩ for fast skel-
etal muscle fibers. To patch motor neurons, positive
pressure (65 mmHg) was applied to the recording elec-
trode via a pneumatic transducer (Fluke Biomedical
DPM1B, Everett, WA). Once the electrode was driven
through the dura in order to approach the targeted
motor neuron, the positive pressure was reduced to 35
mmHg. Fast skeletal muscle fibers were exposed and
subsequently patched by first removing the superficial
layer of slow muscle fibers with a glass suction pipette.
Motor neurons were held at − 65 mV in current clamp
mode and 2msec current injections of ~ 400 pA were
used to evoke action potentials. Muscle cells were held
at − 50mV in voltage clamp mode. External bath record-
ing solution contained the following (in mM), 134 NaCl,
2.9 KCl, 2.1 CaCl2-H20, 1.2 MgCl2, 10 Glucose, 10
HEPES with pH adjusted to 7.4, and osmolarity to 290
mOsm. Motor neuron and muscle cell internal solution
contained the following (in mM), 115 K-Gluconate, 15
KCl, 2 MgCl2, 0.5 EGTA, 4Mg-ATP, 10 HEPES pH 7.2,
290 mOsm. All reagents were obtained from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise noted.
Patch electrodes contained 40 μM Alexa Fluor 488 (Life
Technologies Ltd., Paisley, UK). Physiological recordings
were made with an Axopatch 700B amplifier and digi-
tized with a Digidata 1440A (Molecular Devices, Fre-
mont, CA, USA). pClamp software (Molecular Devices,
Fremont, CA, USA) was used to acquire electrophysio-
logical data. Motor neuron recordings were acquired at
a sampling rate of 50 kHz and postsynaptic currents
were acquired at 100 kHz. Recordings were low pass fil-
tered at 2.2 kHz. Series resistance was monitored for
muscle cell recordings and was < 10MΩ. Data were ana-
lyzed with Clampfit (Molecular Devices, Fremont, CA,
USA), Igor Pro 6.34 (WaveMetrics, Lake Oswego, OR),
and Excel 2010 (Microsoft, Redmond, WA, USA). Sum-
mary data are presented as average ± SEM.
Electron microscopy
6dpf larvae were fixed in 2% glutaraldehyde and 2%
paraformaldehyde in cacodylate buffer 0.1M pH 7.4 to
which 3mM of CaCl2 was added for 2 h at RT. Samples
were washed 3 times in cacodylate buffer 0.1 M pH 7.4
and then post-fixed with 1% osmium tetroxide in dis-
tilled water for 1 h at 4 °C. After an extensive wash (3 ×
10 min) with distilled water they were incubated for 1 h
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in 5% uranyl acetate in water. They were then dehy-
drated in a graded series of ethanol solutions (2x5min
each): 50, 70, 80, 90, and 100%. Final dehydration was
performed twice in100% acetone for 20 min. Samples
were then progressively infiltrated with an epoxy resin,
Epon 812® (EMS, Souffelweyersheim, France): 1 night in
50%resin 50%acetone at 4 °C in an airtight container,
2x2h in pure fresh resin at room temperature. They were
embedded in the bottom of capsules (Beems size 3, Ox-
ford Instruments, Saclay, France) and the resin was poly-
merized at 60 °C for 48 h in a dry oven. Blocks were cut
with an UC7 ultramicrotome (Leica, Leica Microsys-
temes SAS, Nanterre, France). Semi-thin sections
(0.5 μm thick) were stained with 1% toluidine blue in 1%
borax. Ultra-thin sections (70 nm thick) were recovered
either on copper (conventional morphology) or nickel
(immunoelectron microscopy) grids and contrasted
Reynold’s lead citrate. Ultrathin sections were observed
with a Hitachi HT7700 electron microscope (Elexience,
Verrière-le-Buisson, France) operating at 70 kV. Images
were taken with an AMT41B camera at low (× 53,000),
medium (× 70,000), and high (× 110,000) magnification,
the last of which was used for quantification, done with
ImageJ.
Quantitative RT-PCR
Total RNA was extracted from previously phenotyped
6dpf embryos using a standard TRIzol reagent protocol
(ThermoFisher Scientific). cDNA was then synthesized
using the retrotranscription SuperScript III First-Strand
Synthesis system kit (ThermoFisher Scientific) with the
random hexamer primers. The qRT-PCR mix was pre-
pared in technical triplicates with SYBR Green Master
Mix (ThermoFisher Scientific) and run on an ABI
PRISM 7900HT Real-Time PCR System (ThermoFisher
Scientific) using ef1a and rpl13a as reference genes [47].
The analysis was performed according to the deltaCT
quantification method and presented as a relation to
wild-type levels (fold-change) [48].































Data compilation and analysis were done using Excel
(Microsoft, USA) and graph generation was done using
GraphPad Prism version 6 for Windows (GraphPad Soft-
ware, USA). Using GraphPad, Student’s t-test was used
for normally distributed data and Mann-Whitney U test
was used for non-normally distributed data, when com-
paring mutants and wild-types. For comparison of mul-
tiple groups, SigmaPlot 11.0 integrated with SigmaStat
3.1 was used and a one-way ANOVA on ranks was per-
formed, followed by Dunn’s multiple comparison pro-
cedure (pairwise). The Z-test was used to compare
population proportions. Significance, set at p ≤ 0,05 (*),
p ≤ 0,01 (**), p ≤ 0,001 (***).
Results
Establishing a model for Dynactin1 depletion
Previous work has yielded mikre oko m632 (mokm632) a
transgenic line harboring a point mutation within the
coding sequence for dynactin1a, a zebrafish ortholog for
DCTN1 [37]. The C to T transition at nucleotide 2395
creates a premature stop codon and severely reduced
dynactin1a mRNA in mokm632−/− embryos [39]. A subse-
quent absence of a detectable truncated peptide suggests
the mutation is amorphic or strongly hypomorphic [49].
Homozygous mutants larvae do not survive past the sec-
ond week of development, as has been described before
[38]. As Dynactin1 loss-of-function has proven to be
embryonic lethal in other models [50, 51], this suggests
that maternal contribution of Dynactin1a in the zebra-
fish model is sufficient to ensure early survival.
Maternally-provided protein is depleted by 4dpf [52] and
we observed a nearly 70% reduction in protein level in
homozygous embryos at 2dpf (Additional file 1: Figure
S1b, c). This level is comparable to what has been
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achieved by cell culture siRNA silencing of DCTN1 in
previous studies [53].
At early stages, mokm632−/− embryos are indistinguish-
able from their wild-type siblings, and by 4 days post-
fertilization (dpf) exhibit smaller eyes with protruding
lenses, a morphological phenotype resulting from cell
death in the photoreceptor layer, also rendering them
blind [38]. No additional morphological phenotype was
visible in 6dpf homozygousmutant larvae (Additional file 1:
Figure S1a) and heterozygous carriers are adult-viable and
morphologically indistinguishable from wild-type siblings.
Dynactin1a depletion does not affect initial development
of the CaP motor neurons, but leads to growth defects
and abnormal innervation of fast-twitch muscle fibers
In order to determine if reduced levels of Dynactin1a
had an effect on the development of motor neurons, led
to their degeneration, or impaired their function, we fo-
cused our attention on the trunk and tail, more specific-
ally, the CaP motor neurons of the spinal cord [54]. The
CaPs innervate fatigable type II (fast-twitch) muscle fi-
bers as early as 22–24 h post-fertilization (hpf ), forming
an early but functional NMJ by 2dpf [55].
We visualized CaP morphology in live embryos by
single-cell expression of a membrane-bound fluoro-
phore. This was achieved by injection in zygotes of a
DNA construct where lyn-GFP was put under the con-
trol of the mnx1 transcription factor, selectively
expressed in postmitotic motor neurons of the spinal
cord [56]. Comparing cell tracings in mokm632−/− em-
bryos with their wild-type siblings revealed that the
complexity of axonal arbors, defined by total cell length,
projection number, and complexity by branch order, was
not altered at 2dpf (Fig. 1a, b). CaPs in 6dpf mokm632−/−
larvae exhibited a significantly smaller arbor, which was
also less complex, as determined by a reduced total cell
length and number of projections (Fig. 1c, d).
We next examined NMJ integrity by performing double-
immunohistochemistry on fixed embryos. Presynaptic
structure was revealed by labeling of Synaptotagmin-2
(Additional file 2: Figure S2a, c, in green) and the postsyn-
aptic receptors were labeled by a fluorophore-conjugated
α-bungarotoxin (Additional file 2: Figure S2a, c, in red),
which binds irreversibly to the acetylcholine receptors
(AChR) present on muscle fibers. Analysis revealed no
change in colocalization or correlation of both signals in
the 2dpf ventral root (Additional file 2: Figure S2b), indicat-
ing that pre- and postsynaptic components are well aligned
and that CaPs, along with the other motor neurons present
in the ventral root, properly innervated their target muscle
in mokm632−/− embryos at 2dpf. These results indicate that
Dynactin1a depletion does not interfere with initial devel-
opment of the CaPs, as the cell size and synaptic structure
of the NMJ are conserved in 2dpf mokm632−/− embryos.
However, we found reduced coverage of pre- and postsyn-
aptic markers in 6dpf mokm632−/− larvae, consistent with
the observed smaller arbor, but also reduced colocalization
of both markers as shown by lower Pearson’s and overlap
coefficients (Additional file 2: Figure S2d). As we did not
detect orphan vesicles or receptors at 6dpf, our results sug-
gest that the smaller arbor size is due to improper growth
rather than degeneration.
These results indicate that depletion of Dynactin1a
leads to proper migration and initial development of
CaP motor neurons and their NMJ, but to growth de-
fects at 6dpf associated with a compromised NMJ struc-
tural integrity.
Dynactin1a depletion does not alter distribution of
cargoes or axonal transport dynamics
Since Dynactin1 is thought to regulate and direct dynein
activity, and acts as the dynactin complex’s only direct
link with microtubules, we hypothesized that if dynein-
mediated retrograde transport was reliant on Dynactin1a
as an essential part of the dynactin complex, a depletion
could reduce the number of assembled dynactin com-
plexes available and cause defects in clearing of damaged
organelles and detritus, or could affect signaling from
the synapse. Alternatively, as Dynactin1 is known to be
involved in the coordination of bidirectional movement
[57], depletion could affect supply for a growing synapse
by anterograde transport. We then sought to determine
if Dynactin1a depletion caused axonal transport defects
in CaP motor neurons of 2dpf embryos, and if this could
be the cause of the reduced arbor size observed at 6dpf.
To exclude the influence of an aberrant morphology on
this process, we focused this analysis on 2dpf embryos,
which still present normal CaP morphology,
We selected general cargo markers and generated fu-
sion protein constructs to analyze the axonal transport
dynamics of mitochondria (labeled by phb-GFP) [44],
early endosomes (labeled by rab5c-GFP), late endo-
somes/multivesicular bodies (labeled by rab7-GFP), and
recycling endosomes (labeled by rab11a-GFP) in vivo.
To effectively target CaP motor neurons, we used the
GAL4/UAS system and relied on injection of DNA con-
structs in the Tg(mnx1:GAL4) transgenic background
with a co-expressed membrane-bound fluorophore re-
porter (UAS:tagRFP-Caax) to confirm cell type by
morphology (Additional file 3: Figure S3a).
We first assessed cargo distribution in CaP cells, as
disruption of retrograde transport could lead to the for-
mation of aggregates or to abnormal distribution, where
cargo would amass at one end of the distal end of the
cell if only being transported anterogradely. Further-
more, transport defects could affect the fusion and fis-
sion of endosomal vesicles and mitochondria, a process
that is essential to their function and if impaired, would
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alter their size. We quantified number, mean area, total
area (coverage) of all labeled cargoes, as well as their
axonal distribution with relation to the cell body in 2dpf
CaPs (Additional file 3: Figure S3b). No significant dif-
ference was observed for these metrics in mok m632−/−
embryos when compared with their wild-type siblings,
Fig. 1 Dynactin1a depletion leads to proper initial development of the CaPs but impaired growth. Axonal morphology of CaP primary motor neurons
in vivo at a 2dpf, and at b 6dpf visualized in confocal z-stack projections by single-cell expression of membrane-bound mnx1:lyn-GFP, with NeuronJ
tracings of the axonal arbor. Quantification of the tracings for size (total cell length and projection number) and complexity (projection number by
branch order) of CaPs, c showing no significant difference in size between cells of mutants and wild-type siblings at 2dpf, but d revealing that CaPs in
6dpf homozygous mutant larvae have a smaller arbor composed of fewer projections, which retain average length when compared with their wild-
type siblings. All data presented as average +/− SD. (b: n cells wild-type, mutant = 9, 9; d: n cells = 11,14). Scale bar = 50 μm
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and no aggregates were seen, indicating a normal distri-
bution of cargoes.
In order to determine if Dynactin1a depletion modi-
fied axonal transport dynamics, we performed in vivo
time-lapse imaging of single CaP axonal segments,
located at mid-axon. This allowed the quantification of
axonal transport of cargoes in single cells, by kymogram
analysis of transport (Additional file 4: Figure S4a). We
first classified each cargo trace into three net transport
states based on their movement during the acquisition
period, whether they were immobile (black), moving
toward the cell body (retrograde, magenta) or moving
toward the synapse (anterograde, cyan). We found no
significant difference in the percentage of cargo in each
state between mok m632−/− embryos and their wild-type
siblings (Additional file 4: Figure S4b). We then quanti-
fied metrics such as area flux in the retrograde direction
and in the anterograde direction (Additional file 4:
Figure S4c, d), and axonal segment vesicle density (Add-
itional file 4: Figure S4e). In addition, we also
determined average run speed, length, and duration for
runs in both the retrograde and the anterograde direc-
tion (example traces on Additional file 4: Figure S4a;
Additional file 5: Figure S5). Surprisingly, we did not
find any significant difference in these measurements
when comparing mok m632−/− embryos with their wild-
type siblings.
These results suggest that the extent of Dynactin1a de-
pletion at 2dpf does not affect distribution, anterograde
or retrograde axonal transport of mitochondria, and
early, late, and recycling endosomes in CaP motor
neurons.
Cytoskeleton dynamics are not affected by Dynactin1a
depletion
The growth defects observed at 6dpf could be due to the
switch in growth signals between a migrating axon, di-
rected by guidance cues [58, 59], and a maturing arbor,
responding to local trophic signaling [60, 61]. Indeed,
trophic signaling is essential for the growth and plasticity
of CaP arbors. The actin cytoskeleton will form filopodia
to search the environment for guidance cues, trophic
signaling and adhesion molecules provided by the
muscle fibers [62]. These structures get infiltrated by mi-
crotubules to form nascent branches, once stabilized by
post-synaptic partners, [63], or are retracted when
proper signal is absent [64]. Proteins localizing at micro-
tubule +ends (like Dynactin1) are known to regulate the
actin cytoskeleton and mediate the signaling of guidance
cues during neuronal development [65].
In order to determine if Dynactin1a depletion inter-
fered with the actin cytoskeleton stabilization or with
trophic signaling, we monitored filopodia dynamics via
in vivo time-lapse imaging of CaP cells expressing
lynGFP (Fig. 2a). We quantified the amount of unstable
filopodial extensions by means of total length, total
number and average length of unstable filopodia at 1dpf,
2dpf, 3dpf and 4dpf, but found no significant differences
between mok m632−/− embryos and their wild-type
siblings aside from a slight reduction in total length of
unstable filopodia at 2dpf (Fig. 2b). To confirm that loss
of Dynactin1a did not alter trophic signaling, we also
performed axonal transport analysis of vesicles contain-
ing the survival/suicide low-affinity trophic receptor p75
(ngfra), and found no difference in ratios, area flux or
transport metrics (Additional file 6: Figure S6). Because
we only observed a slight reduction in total length of un-
stable filopodia at 2dpf, without additional defects in
other metrics like average length and filopodia number,
as well as no in changes trophic signaling, we deemed
this change not biologically relevant and moved on to
the analysis of the microtubule cytoskeleton.
As Dynactin1 is known to bind microtubules via its
CAP-Gly domain, and to act at as an anti-catastrophe
factor at plus-tips (+tips) [66], we then investigated
microtubule growth by quantification of EB3 comets.
This +tip protein binds the labile end of the tubules dur-
ing bouts of assembly and the resulting runs, or
“comets” were visualized in vivo by time-lapse imaging
of fusion proteins in single CaP arbors at 2dpf and 6dpf
(Fig. 2c). Quantification of comet metrics like average
distance, time and speed of runs, did not reveal any
changes in either timepoints when comparing mok m632
−/− embryos with their wild-type siblings (Fig. 2d), sug-
gesting microtubule growth and stability are not affected
by Dynactin1a depletion.
Microtubule capture at synapses is known to rely on
the dynein/dynactin complex and its interaction with ad-
hesion molecules to anchor microtubules at the mem-
brane and promote synapse stability [67]. We therefore
co-expressed our EB3 comet construct described previ-
ously with rab3-tagRFP, a marker for putative synapses
[45], to label both growing microtubules and putative
synapses within the same CaP arbor in live 2dpf and
6dpf embryos (Fig. 2e). We then performed time-lapse
imaging to determine the density of terminating comets
and of synapses in terminal branches of the axonal
arbor. The ratio of microtubule capture, defined by
comets terminating their run at putative synapse sites,
for mok m632−/− embryos was unchanged when com-
pared with their wild-type siblings (Fig. 2f ). This sug-
gests that synaptic microtubule capture, while
dependent on interaction between dynein and the
dynactin complex [67], is not affected by Dynactin1a
depletion.
These results indicate that the growth defects observed
in 6dpf CaP motor neurons upon Dynactin1a depletion
do not result from impaired modulation of the actin or
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Fig. 2 CaP growth defect is independent of cytoskeleton dynamics modulation. a Actin filopodia dynamics is assayed by time-lapse imaging of
single CaP cell arbors expressing membrane-bound reporter lyn-GFP, from 2dpf to 4dpf. Example of confocal z-stack projection of a 2dpf CaP, with an
overlay showing total unstable filopodia in red. b Quantification of filopodia dynamics over 10min reveals no change in total unstable filopodia length,
number or average length for 1dpf, 2dpf, 3dpf or 4dpf cells, with the exception of total unstable filopodia length at 2dpf, which was found to be slightly
diminished. c Microtubule growth was determined by time-lapse imaging of eb3-GFP comets at both 2dpf and 6dpf. d Quantification of extracted
kymograms shows no change in microtubule growth at either timepoint, as determined by average distance, duration and average speed of comet runs.
e Microtubule capture at putative synapses was assayed by expression of a synaptic marker (rab3-tagRFP, in red) simultaneously with eb3-GFP (in green) at
2dpf and 6dpf. f Quantification of microtubule capture at putative synapses, density of terminating eb3 comets or putative synapses per axonal segment
reveal this process was not affected by loss of Dynactin1a. Data presented as average +/− SEM. (b: 1dpf n= 10,5; 2dpf n= 8,10, 3dpf n= 8,8, 4dpf n= 6,10;
d: 2dpf n= 24, 22, 6dpf n= 22,20; f: 2dpf n= 15, 28, 6dpf n= 8,12)
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microtubule cytoskeleton, and that the cell has both the
potential for sensing and the support for trophic signal-
ing in mok m632−/− embryos.
Dynactin1a depletion leads to synapse instability at the
NMJ
Synapses are known to be necessary for the stabilization
of new branches in a growing axonal arbor [67] and pre-
vious studies suggested a role for Dynactin1a in synapse
growth and stability in Drosophila [68, 69]. While we did
not observe a change in microtubule capture, defects in
local organization of the presynaptic structure could lead
to instability and impair growth of the CaPs.
Double immunohistochemistry on whole-mount prep-
arations revealed overall conserved NMJ structural in-
tegrity for all motor neurons present in the ventral root
at 2dpf (Additional file 2: Figure S2 a, b). In order to ob-
serve CaP synapses specifically, we labeled single neu-
rons by injecting pUAS-dendra2-rab3 in the Tg(mnx1:
GAL4) transgenic background. We observed the size and
coverage of putative synapses in single cells of live mok
m632−/− and wild-type embryos at 2dpf (Additional file 7:
Figure S7a), where no difference was found in number,
average size, and arbor coverage (total area) of putative
synapses between mok m632−/− embryos and their wild-
type siblings (Additional file 7: Figure S7b). However, la-
beling of CaP synapses in live 6dpf larvae (Fig. 3a) re-
vealed that the smaller cell arbors seen in mok m632−/−
embryos contain less synapses, which are also of smaller
size (Fig. 3b).
We then performed time-lapse imaging on CaP arbors
over a period of 3 h, a benchmark lifetime for putative
synapse stabilization [67] (Fig. 3c) in order to assess if
Dynactin1a depletion led to instability at 2dpf which
could explain the reduced number of NMJ synapses in
6dpf arbors. While we had not found significant differ-
ences for number of synapses between wild-type and
mok m632−/− embryos at 2dpf (as shown in Add-
itional file 7: Figure S7b), comparison of the same cell
between the two timepoints (initially and 3 h later)
allowed quantification of synapses lost and gained over
this period, represented as fold-change. We found re-
duction in number and arbor coverage (total area) of pu-
tative synapses in 2dpf mok m632−/− embryos when
compared with their wild-type siblings, while average
size (mean area) was maintained (Fig. 3d). In addition to
microtubule capture, which was found to be unchanged
in our mutant (Fig. 2e, f ), synapse stability also relies on
interaction with adhesion molecules. We investigated
localization of N-Cadherin at NMJ synapses by using
previously described BAC transgenic Tg(cdh2:Cdh2-GFP)
[41]. At the NMJ, N-Cad-GFP forms a puncta at the
center of the presynaptic structure and this localization
was not perturbed in 2dpf (Additional file 8: Figure S8a)
or 6dpf mok m632−/− embryos (Additional file 8: Figure
S8b). As N-Cadherin is known to be involved in synapse
stabilization by mediating cell-cell interactions, our re-
sults suggest that synapse instability is not due to
impaired localization of this adhesion molecule at the
synapse, although defects could still arise from compro-
mised interactions upon depletion of Dynactin1a.
These results indicate that Dynactin1a depletion im-
pairs synapse stability at 2dpf, independently of proper
localization of N-Cadherin, and leads to impaired
stabilization of nascent branches of growing CaP motor
neuron arbors and a reduced number of putative synap-
ses at 6dpf.
Ultrastructural analysis of NMJ synapses support a local
role for Dynactin1a
Visualization of the 6dpf NMJ by electron microscopy
(Fig. 3e) confirmed the lack of aggregates in synaptic ter-
minals of mok m632−/− larvae which could have sup-
ported defects in axonal transport. In addition, we found
that the synaptic vesicles were of similar average size
and density throughout the terminal in both mutant and
wild-type larvae (Fig. 3f ). Although they appeared less
clustered, it was not possible to determine if
organization of vesicle pools was maintained in mok
m632−/− larvae. When looking at the active zone (AZ)
perimeter (yellow circle Fig. 3e), we observed normal
density of synaptic vesicles, which exhibited a similar
distribution in relation to the center of the AZ (Fig. 3g),
suggesting no change in the availability of vesicles as
part of the readily-releasable pool. However, the synaptic
cleft as measured between the neuron membrane and
the muscle at the level of the AZs, was significantly
wider in mok m632−/− larvae (Fig. 3g). These observations
indicate that despite the lack of changes in microtubule
capture at synapses or in the localization of N-cadherin,
Dynactin1a could have a role in active zone structure
and organization.
Synapse instability leads to impaired NMJ function and
locomotion defects
To determine if synapse instability and wider synaptic
clefts had functional consequences on synaptic transmis-
sion, we performed whole-cell voltage clamp recordings
of individual fast-twitch skeletal muscle fibers and moni-
tored spontaneous miniature end plate currents (mEPCs,
Fig. 4a). We observed that mEPCs from the muscle of
6dpf mok m632−/− larvae and of their wild-type siblings
shared similar kinetics (Fig. 4b, Additional file 9: Figure
S9a, b), frequencies (Fig. 4c) and amplitudes (Fig. 4d) of
mEPC, as well as a similar quantal size for spontan-
eously released single vesicles from the CaP [70] (Fig. 4e),
suggesting that even with severely reduced levels of
Dynactin1a, the synaptic vesicles in CaPs motor neurons
Bercier et al. Molecular Neurodegeneration           (2019) 14:27 Page 11 of 22
Fig. 3 (See legend on next page.)
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are released normally, that they contain usual quantities
of neurotransmitter and that the postsynaptic ACh re-
ceptors on fast-twitch muscle fibers are not affected.
In order to investigate the consequence of Dynactin1a
depletion on evoked neurotransmission, we next per-
formed paired whole-cell patch clamp recordings of CaP
motor neurons and of their target fast-twitch skeletal
muscle [70] (Fig. 4f ). In current clamp mode, a short
pulse of current (2 msec, ~400pA) was injected into the
CaP motor neuron to elicit an action potential (AP)
(Fig. 4g, upper trace) and the subsequent EPC was re-
corded in an innervated muscle fiber in voltage clamp
mode (Fig. 4g, lower trace). While quantal content for
the AP-evoked EPCs in muscle fibers were not different
in mok m632−/− larvae (Fig. 4h), we observed variability
in EPC amplitude (Fig. 4i, j) and half of the motor neu-
rons tested displayed a higher number of EPC failures.
These failures, where CaPs fail to release neurotransmit-
ters, occur at a higher rate during 10 Hz, 20 Hz and 100
Hz stimulation (traces shown for 1 Hz in Fig. 4i and 100
Hz in Fig. 4j, Fig. 4k, labeled failures in mutant traces,
Fig. 4l quantification) (additional frequencies Add-
itional file 9: Figure S9c).
Because we could not perform paired recordings at
2dpf, we then tested if the observed synaptic instability
led to locomotion defects at 2dpf. We performed a
touch-evoked escape response (TEER) assay where
embryos produce stereotypical swimming episodes in
response to touch stimuli (traces of escapes Fig. 5a). The
escapes produced by mok m632−/− embryos were of
shorter duration and covered less distance than the ones
of their wild-type siblings (Fig. 5b). Furthermore, the
maximum instant speed, a readout for muscle function
[71], was not affected by Dynactin1a depletion (Fig. 5b).
As swimming is a complex behavior that requires
synchronous activity of spinal cord neurons, we used
optogenetics to exclude the possibility that the ob-
served phenotype arose from impaired circuit con-
nectivity upstream of the CaPs. We probed
recruitment of motor neurons in the spinal cord dur-
ing fictive swimming upon presentation of water jet
stimuli (Fig. 5c) while monitoring neuronal activity in
the spinal cord with a genetically-encoded calcium in-
dicator (Tg(mnx1:GAL4; UAS:GCaMP5, Fig. 5d). No
differences in maximum DF/F amplitude signal for
each cell analyzed were noted in 4dpf mok m632−/−
larvae when compared with their wild type siblings
(Fig. 5e). This indicates that CaPs have normal cal-
cium transient when stimulated, and that there are no
connectivity defects upstream of the CaP motor
neurons.
These results suggest that Dynactin1a depletion leads
to electrophysiological abnormalities at the NMJ, where
the synaptic instability observed in 2dpf CaPs of normal
morphology leads to functional deficits at the NMJ cul-
minating in abnormal locomotion, without affecting
muscle function, and where 6dpf mok m632−/− larvae dis-
played varying EPC amplitudes and a higher rate of
failures in response to action potential, while still main-
taining normal spontaneous release kinetics and quantal
content.
Expression of human Dynactin1-eGFP rescues defects in a
cell-autonomous manner
To confirm that the phenotype observed in our mok
m632−/− larvae did not involve the muscle fiber or sur-
rounding glia, we specifically overexpressed wild-type
human Dynactin1-eGFP (DCTN1-eGFP) together with
an E2A-linked membrane-bound fluorophore reporter
(tagRFP-Caax) in single CaP neurons. At 2dpf, over-
expression of DCTN1-eGFP did not have an effect on
CaP morphology either in mok m632−/− embryos or
their wild-type siblings (Additional file 10: Figure S10
a, b). At 6dpf however, the human protein was able
to rescue the morphological phenotype in mok m632
−/− larvae (Fig. 6a), as mutant CaPs had larger, more
complex axonal arbors than wild-type CaPs, based on
total cell length and number of projections, while
maintaining average projection length (Fig. 6b). This
overgrowth in rescued CaPs is most likely due to lack
of competition from neighboring cells, lacking
Dynactin1-eGFP, and still exhibiting a reduced axonal
arbor due to Dynactin1a depletion. Overexpression of
Dynactin1-eGFP in 6dpf wild-type CaPs did not affect
(See figure on previous page.)
Fig. 3 Dynactin1a depletion leads to synapse instability at 2dpf, reduced synaptic density at 6dpf and ultrastructural changes. a Putative synapses
are visualized with rab3-dendra2 labeling in single CaP cells at 6dpf. b Synaptic coverage in the arbors, determined by number, average area and
total area, of putative synapses is reduced in 6dpf larvae in homozygous mutant embryos when compared with their wild-type siblings. c Synapse stability
at 2dpf was assayed by imaging cell arbors over a period of 3 h, where comparison of the initial stack (t = 0) with the subsequent one (t = 3 h) for the
same cell was used to determine the number of stable synapses. Examples of synapses added and lost are indicated in green and red arrows respectively.
d Quantification is presented as fold-change and reduced in homozygous mutant embryos for number and total area, but not for mean area of putative
synapses, when compared with their wild-type siblings. e Electron micrograph of a transverse section of the 6dpf NMJ, with close-up (dashed yellow box),
showing active zones (center of yellow circle) in NMJ synapses of mok m632−/− larvae and their wild-type siblings. f No changes were detected in number
of synaptic vesicles and average vesicle size when measured in the synaptic terminal. g Normal density and distribution of vesicles was also observed
around the active zones (yellow circle perimeter), however the synaptic clefts were significantly wider at mok m632−/− larvae active zones. Data shown as b)
d) average +/− SD, f) g) average +/− SEM. (c: n cells = 11,7; d: n cells = 17,15, f: n slices = 14, 14; g: n active zones = 34,22). Scale bar a) c) 50 μm; e) 500 nm
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cell morphology, similar to what was observed at
2dpf. These results suggest that loss of Dynactin1a is
acting in a cell-autonomous manner to cause a mor-
phological phenotype and that human wild-type
Dynactin1-eGFP can rescue these defects in mok m632
−/− embryos. Furthermore, we observed an enrichment
of Dynactin-eGFP at synaptic termini at 6dpf arguing
for a local role at this site (Fig. 6a, c).
Expression of human Dynactin1-GFP rescues behavioral
deficits
To confirm that expression of human wild-type Dynactin1
rescued neuromuscular function in mokm632−/− embryos,
we synthesized RNA encoding Dynactin1-GFP and
injected it in 1–2 cell stage eggs. This resulted in a broad
expression of the protein throughout the embryo, as de-
tected by GFP signal (Additional file 10: Figure S10c),
Fig. 4 NMJ function is impaired by severely reduced levels of Dynactin1a. a Sample traces of spontaneous miniature end plate currents (mEPCs)
from fast-twitch muscle fibers. b Normalized individual mEPCs from mok m632−/− larvae (blue trace) and their wild-type siblings (black trace). c
Average mEPC frequency recorded from wild-type and mutant mok m632−/− larvae. d mEPC amplitude histogram for wild-type and mok m632−/−
larvae with Gaussian functions (red traces). e Normalized Gaussian fits from wild-type (black trace) and mok m632−/− larvae (blue trace). f Paired
motor neuron skeletal muscle fiber recording each patched and filled with AlexaFluor 488 (calibration bar = 100um). g Motor neuron action potential is
evoked by a 2msec current injection (upper trace) and subsequent muscle EPC is recorded (lower trace). h Average quantal content (evoked EPC
amplitude/mEPC amplitude for wild-type and mok m632−/− larvae. Sample traces from paired neuron – muscle whole cell recordings for wild-type and mok
m632−/− larvae with stimulus frequencies of i 1 Hz and j 100Hz. k Magnification of evoked EPCs from mok m632−/− larvae recordings demonstrating
postsynaptic EPC failures occurring at 10, 20 and 100 Hz (red asterisks). l Evoked EPC failure rate is significantly higher in mok m632−/− (blue trace) than in
wild-type larvae (black trace) for paired recordings 10 Hz, 20 Hz and 100 Hz. Data shown as mean +/−SEM. (c: average = 35.04 ± 9.25, n= 2638 events from
15 fish/ average = 40.86 ± 7.53, n= 4903 events from 24 fish; d: n= 2638 events from 15 fish/ n= 4903 events from 24 fish; d: WT peak 1 average = 18.35,
WT peak 2 average = 283.19, mutant peak 1 average = 20.42, mutant peak 2 average = 280.00; h: QC = 9.39 ± 3.31, n= 8 pairs/ QC = 10.98 ± 2.59, n= 18
pairs; l: n= 8 pairs/ n= 9 pairs)
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allowing us to perform the 2dpf TEER assay described
previously. The escapes produced by mok m632−/− and
mok m632−/+ embryos injected with Dynactin1-GFP were
of similar duration and distance while being significantly
different from uninjected mok m632−/− (Fig. 6d). These re-
sults show that exogenous Dynactin1-GFP expression can
rescue the locomotion abnormalities described in our mu-
tants and thus rescue neuromuscular function.
Overall, our results in CaP motor neurons of the zeb-
rafish spinal cord support a role for Dynactin1a in NMJ
dysfunction, where it acts locally to ensure synapse sta-
bility and function, independently of its role in regulat-
ing dynein activity, directing axonal transport or in
modulating cytoskeleton dynamics.
Discussion
In this study, we characterized a progressive Dynac-
tin1a depletion in vivo, focusing specifically on its ef-
fect on primary motor neurons of the zebrafish spinal
cord. We report here that loss of Dynactin1a is suffi-
cient to impair primary motor neuron function, where
CaP motor neurons exhibit impaired growth of axonal
arbors, neuromuscular junction synapse instability and
functional abnormalities culminating in locomotion
defects.
A striking result of this study is the lack of detectable
impact on axonal transport and cytoskeleton dynamics
in dynactin1a mutants. It is now well demonstrated that
genetic mutations can lead to upregulation of related
Fig. 5 NMJ dysfunction leads to behavioral deficits. a NMJ functional defects lead to impaired locomotor behavior in 2dpf embryos as
determined by touch-evoked escape response assay. Escape traces extracted from video tracking of escape swimming episodes following the
presentation of a stimulus for 10 embryos per genotype shown here as an example. b Quantification of escapes reveal that Dynactin1a depletion
leads to impaired locomotion determined by reduced escape duration and distance, but without altering maximum instant speed. c Calcium
imaging of fictive escape responses in motor neurons expressing GCaMP5 was performed in the spinal cord upon presentation of a water jet
stimulus. d GCaMP5 expression was confined to motor neurons and analysis of calcium signals was performed on dorsally-located primary motor
neurons (region of interest in red). e Example of calcium signals obtained from primary motor neurons including CaP motor neurons in mok
m632−/− larvae (red) and their wild-type siblings (black) at 4dpf; one trace per cell, four fictive escape responses are represented to show response variability.
f Maximum DF/F amplitude signal in dorsal motor neurons averaged per fish and plotted according to the stimulation number, showing proper recruitment
of spinal cord motor neurons despite reduced levels of Dynactin1a. Data shown as b) median +/− interquartile range (b: n= 76,101; f: n embryos/n cells = 6/
63, 8/44) Scale bar 100 μm
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genes and potentially to functional compensation for
loss of the protein encoded by the mutated gene [72].
Due to genome duplication, the zebrafish has another para-
log for DCTN1: dynactin1b (ZV11; ENSDARG00000056753)
that could account for such a compensation. Previous
assemblies of the zebrafish genome (ZV8 and ZV9) predict a
shorter protein produced from this gene, homologous to the
p135 isoform of Dynactin1 [73] lacking the microtubule-
binding CAP-Gly domain as a result of alternative splicing. As
we did not observe a change in the expression of this paralog
Fig. 6 Overexpression of human wild-type DCTN1 rescues the CaP growth defects at 6dpf and the behavioral deficits at 2dpf. a CaP morphological
defects seen at 6dpf in mutant larvae are rescued by single-cell overexpression of DCTN1-GFP. b Quantification of cell tracings show recovery of arbors size
in rescued mutant larvae, as determined by total projection number and total cell length, without affecting average projection length. Overgrowth is due
to lack of competition by neighboring mutant cells. c DCTN1-GFP is found to accumulate at synaptic sites (close-up of heatmap), d as confirmed by
colocalization (in white) in double immunohistochemistry of DCTN1-GFP (anti-GFP in cyan) with post-synaptic ACh receptors (α-bungarotoxin, in magenta).
d Overexpression of exogenous DCTN1-GFP by injection of 400 ng/ul RNA rescued the NMJ functional defects leading to impaired locomotor behavior in
2dpf embryos. Touch-evoked escape response was quantified and is shown as ratios relative to the average values obtained for wild-type escapes for
duration, distance, and maximum instant speed. Data shown as c) average +/− SD, d) median +/− interquartile range (b: n cells = 19, 13; d:n embryos = 26,
24, 19). Scale bar = 50 μm
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in mokm632−/− larvae by qRT-PCR (Additional file 1: Figure
S1d), we conclude that loss of dynactin1a does not trigger a
genetic compensation by dynactin1b, however it still could be
acting in functional redundancy. We were unable to amplify
by RT-PCR a dynactin1b cDNA containing the predicted
CAP-GLY domain (exons 1–3) in either mokm632−/− or wild-
type embryos (data not shown), further supporting the
hypothesis that the domain is not included in the wild-type
mRNA, and does not get spliced in following dynactin1a
silencing. Consequently, dynactin1b likely leads to a protein
similar to the 135 kDa isoform, which could explain why we
do not see drastic changes in axonal transport. Indeed, both
isoforms are found in neuronal populations [74] and bind dy-
nein in independent complexes [73]. Because dynein alone
binds well to stable, detyrosinated microtubules, while it
requires both the dynactin complex (with the full-sized Dynac-
tin1) and adaptor BicD2 to interact with tyrosinated microtu-
bules such as the ones found at the dynamic (+) ends [75], the
absence of full-sized Dynactin1a in presence of the short p135
equivalent Dynactin1b would likely only affect the initiation
and not the processivity of transport [76].
We also did not detect changes in modulation of the
cytoskeleton dynamics in mok m632−/− embryos, another
well-described function of Dynactin1 within the dynactin
complex. Indeed, our mutants were found to efficiently
stabilize microtubules at + ends, necessary for the
growth of an axonal arbor, and to capture them at new
synapses, a function which rely on interaction of the
dynactin complex with the dynein motor and NCAM-
180 [66, 67]. Following the initial migration of the
growth cone to reach its target muscle, the cell relies on
cues from the environment in the form of trophic fac-
tors acting in a feedback loop with NMJ activity. BDNF
is known to act as a retrograde signal to stimulate the
maturation of the NMJ synapses by promoting arbor
outgrowth and branching and increasing the production
of synaptic vesicle proteins [77]. We probed actin filo-
podia dynamics to determine if the cell was unable to
locally detect trophic signaling. These metrics were also
found to be unaffected by Dynactin1a depletion, as was
the axonal transport of the survival/suicide trophic re-
ceptor p75 (ngfra). Furthermore, we did not find altered
levels of bdnf mRNA (Additional file 1: Figure S1d),
which could have indicated compensation for the growth
defects by the muscle target. This suggests that Dynac-
tin1a depletion does not lead to changes in the capacity
of the cell to detect or respond to trophic signaling and
that our phenotype is independent of modulation of
cytoskeleton dynamics.
Although transport and cytoskeleton dynamics ap-
peared unaffected, we detected synapse instability and
locomotion abnormalities at 2dpf, before the apparition
of morphological defects, suggesting impaired NMJ
function. Synapses are known to be necessary for the
stabilization of nascent branches of a growing arbor
[67]. As CaPs in mok m632−/− larvae have a reduced
arbor size, containing a lower number of putative synap-
ses which were of smaller size. Thus, a higher loss of
synapses due to instability not compensated by new syn-
apse formation can explain the observed growth defects
and the reduction in putative synapse number at 6dpf.
While changes in axonal transport or cytoskeleton dy-
namics would have easily explained the observed pheno-
type because of the necessity of retrograde transport and
cytoskeleton modulation for signaling and degradation,
our evidence suggests this is not the mechanism at play
upon Dynactin1a depletion.
The locomotion defects detected in 2dpf mok m632−/−
embryos by behavioral assay (TEER) indicate that the
synapse instability observed at this early stage is suffi-
cient to induce functional deficits at the NMJ. Injection
of RNA encoding Dynactin1-GFP to obtain a broad but
transient overexpression led to the rescue of this behav-
ioral phenotype. It is important to note that the ob-
served locomotion deficits, while statistically significant,
were less severe than what has been described in previ-
ous ALS models [78–80]. In patients, impairment of
NMJ function is reported to arise before the onset of
motor neuron degeneration and clinical symptoms in
early ALS [81]. This is consistent with our observations
as Dynactin1a depletion leads to synapse instability and
slight locomotion deficits at 2dpf, before the apparition
of a morphological phenotype in CaP motor neurons
and loss of NMJ structural integrity at 6dpf.
Electrophysiological recordings provided a closer look
at NMJ synaptic dysfunction, showing that the release
machinery is functional at the 2dpf and 6dpf mok m632
−/− synapses and that the quantity of neurotransmitter
contained in individual vesicles was not altered. In
addition, no changes were found in the release kinetics
or receptor properties. However, paired-recordings of
the CaP-fast-twitch muscle fiber at 6dpf revealed that
mok m632−/− NMJs have variable amplitudes and a higher
rate of response failure to action potentials, when stimu-
lated at 10, 20 and 100 Hz, similar to what has been
described for the FUS loss-of-function ALS model [78].
Ultrastructural analysis of the NMJ synapses in 6dpf
mok m632−/ larvae confirmed that we did not have distal
accumulation of aggregates, which would be expected in
the event of impaired retrograde axonal transport, and
showed that the mutant synaptic terminals contained
vesicles which were of similar density and average size
as the one of their wild-type siblings. We also observed
that the active zone perimeter contained similar num-
bers of available vesicles (readily-releasable), however it
was not possible to determine if the formation of synap-
tic vesicle pools, namely the reserve and recycling pools,
was conserved. The synaptic cleft, composed of domains
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connecting the pre- and postsynaptic side of the synapse,
was however wider in mok m632−/ larvae at the level of
the active zones, suggesting that active zone organization
might be disturbed following Dynactin1a depletion. Al-
though we did not investigate this mechanism in more
detail, this Dynactin1 could be involved in generating
force to maintain membrane apposition by interacting
with adhesion molecules or by helping recruit or main-
tain functional pools in synaptic termini.
In our synapse stability assay, we used Rab3, a protein
associated with vesicles at active zones, to label putative
synapses. This protein is essential for neurotransmission,
with a known role in calcium-evoked exocytosis, and
interaction with the SNARE complex [82], and a role in
synaptic vesicle formation and trafficking [83]. More-
over, impaired active zone scaffolding could lead to inef-
fective coupling and recruitment of synaptic vesicles, or
could affect calcium channel clustering, explaining the
failures in response during repeated action potentials
seen in our paired-recordings. Indeed, evoked release
(action-potential-mediated) relies on a nanodomain ac-
tive zone organization for efficient neurotransmission,
whereas spontaneous release, which was unaffected in
our mutant, can occur at varied areas of the terminal
[84]. Hence we speculate that the synapse instability and
EPC amplitude variability, as well as the higher failure
rate reported here is due to improper formation of active
zones following depletion of Dynactin1a, either by inter-
action with adhesion molecules or by recruitment or
maintenance of functional vesicle pools.
Along with the reduced DCNT1 mRNA and protein
levels reported in sporadic ALS patients [26], missense
mutations in DCTN1 have been reported in ALS pa-
tients [28–30, 32]. In the context of a dominant inherit-
ance, these missense mutations could likely lead to
haploinsufficiency, as one out of three outcomes of mis-
sense mutation [85]. In further support of this hypoth-
esis, it was reported that animal models for Dynactin1
mutations lead to a reduction in protein expression, for
instance in the G59S mice [50], or the G38S flies [51],
however the effect of other ALS-related mutations on
protein expression was not studied.
Because many of the ALS-linked mutations were also
found in controls [28, 30, 32], and due to their rarity
and the variability of clinical presentation of ALS pa-
tients, causality was not established, however it was sug-
gested that these mutations could act as risk factors and
compound other rare variants in an oligogenic etiology
of ALS [31]. Indeed, DCTN1 expression was found to be
downregulated in sporadic ALS patient postmortem
spinal cord tissue as an early event preceding degener-
ation as it was observed in neuronal populations that
were well preserved and without pathological markers
for degeneration [25]. Our zebrafish model exhibited an
initial reduced expression of Dynactin1, followed by a
gradual depletion over the course of a few days, thus
representing depletion kinetics of interest in the context
of investigating the role of this protein in ALS
pathogenesis.
Conclusions
The in vivo characterization of the morphogenesis and
function of motor neurons in zebrafish embryos and lar-
vae depleted for Dynactin1a point toward a local role for
this protein in stabilizing the neuromuscular synapses,
impairing its function, without leading to motor neuron
death. This role appears to be independent of Dynac-
tin1’s known functions associated with the dynein motor
in axonal transport or cytoskeleton dynamics modula-
tion, possibly due to the likely presence of the shorter
p135 isoform. Because our probing of interactions with
cytoskeletal components or adhesion molecules did not
reveal anomalies, a candidate approach of possible syn-
aptic interactors of Dynactin1a would be necessary to
help further understand the mechanism at play leading
to NMJ dysfunction in this model. The defects reported
here are milder than what has been described for estab-
lished zebrafish ALS models investigating pathogenic
mutations, but represent targeted impairments which
are consistent with early disease presentation. We there-
fore propose that Dynactin1a depletion represents an
early event in NMJ degeneration and that ALS-related
mutations in this gene are likely not causative but indeed
have a place in the oligogenic etiology of ALS
pathogenesis.
Additional files
Additional file 1: Figure S1. mok m632−/− embryo morphology at 6dpf,
Dynactin1 protein quantification at 2dpf and qRT-PCR expression in mok
m632−/− larvae. a) Wild-type sibling and homozygous mutant embryo
morphology at 6dpf; close-up showing a dorsal view of the head to
emphasize previously described eye phenotype. b) Western blot of
maternally-contributed Dynactin1 in 2dpf mok m632−/− embryo (detected
with anti-DCTN1 antibody from Origene, TA346929), c) quantified against
gamma-tubulin at 32% wild-type level. d) Quantification of 3 biological
replicates of qRT-PCR levels from 6dpf mok m632−/− larvae mRNA relative
to the average wild-type levels obtained for 6dpf m632+/+ larvae mRNA
(presented as fold change) shows no compensation by dynctin1b or kif14,
no change in the expression of other subunits of the dynactin complex
(p22/24, p25, p50, actr1), no change in other known regulators of the dy-
nein motor complex (ndel1b, pafah1b1a/1b1b), and no changes indicative
of trophic compensation (bdnf ). (TIF 45716 kb)
Additional file 2: Figure S2. mok m632−/− embryo and larvae NMJ
structural integrity. a) Double immunohistochemistry reveals the integrity of
the NMJ at 2dpf by coverage and colocalization of presynaptic structures (anti-
synaptotagmin2, in green) and postsynaptic Ach receptors (α-bungarotoxin, in
red). b) Quantification of the colocalization shows normal NMJ structure of the
ventral root at 2dpf by both Pearson’s coefficient and the overlap coefficient. c)
NMJ structure is also affected at 6dpf, with d) reduced coverage in pre- and
postsynaptic components, as well as reduced colocalization. All data presented
as average +/− SD; (b: n embryos = 12, 14; d: n larvae = 11,19) (TIF 32575 kb)
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Additional file 3: Figure S3. Dynactin1a depletion does not alter cargo
distribution. a) Example of cargo labeling, here for late endosomes (rab7-
GFP, in green) co-expressed with a membrane-bound reporter (tagRFP-
Caax, in red) in a single CaP motor neuron. b) The quantification of cargo
size and coverage is done by cell compartment (axon, arbor), and distri-
bution from the cell body is analyzed in the axon for mitochondria (phb-
GFP), early endosomes (rab5c-GFP), late endosomes/multivesicular bodies
(rab7-GFP) and recycling endosomes (rab11a-GFP). No difference is found
for vesicle or organelle number, mean area, total area or distribution be-
tween homozygous mutants and their wild-type siblings at 2dpf. Data
shown as average +/− SD. (n cells b: mitochondria n = 7,6, rab5c n = 5,7;
rab7 n = 7,9; rab11a n = 10,9). (TIF 19764 kb)
Additional file 4: Figure S4. Dynactin1a depletion does not alter
axonal transport dynamics. a) Example of in vivo timelapse imaging still
(t = 0) and extracted kymogram with labelled runs (anterograde cyan,
retrograde magenta). b) Kymogram analysis of cargo states reveals no
change in dynamics (immobile in black, anterograde in cyan and
retrograde in magenta) at 2dpf. In addition, no change was observed in
retrograde or anterograde area flux c) and d), or for cargo density e)
except for mitochondria which was slightly increased. Data shown as
average +/− SEM. (n = kymogram c, d, e: mitochondria n = 5,17, rab5c
n = 7,7; rab7 n = 11,14; rab11a n = 7,11). (TIF 24821 kb)
Additional file 5: Figure S5. Dynactin1a depletion does not alter
transport run dynamics. Additional transport metrics for all cargo shows
no change in average run speed, length or duration of retrograde and
anterograde runs for a) mitochondria, b) rab5c vesicles, c) rab7 vesicles,
or d) rab11 vesicles. Data shown as average +/− SEM. (n = kymogram a:
n = 5,17; b: n = 7,7; c: n = 11,14; d: n = 7,11). (TIF 26989 kb)
Additional file 6: Figure S6. Transport of p75 receptor (ngfra) is not
affected by loss of Dynactin1a. In vivo timelapse imaging of vesicles
tagged with ngfra-eGFP fusion protein show no changes in a) transport
states, b) area flux and vesicle density, c) average run speed, length and
duration of retrograde and anterograde runs of the trophic receptor in
2dpf CaP motor neurons. All data presented as average +/−SEM. (n kymo-
gram = 10,9). (TIF 16813 kb)
Additional file 7: Figure S7. Synapse distribution and size at 2dpf is
not affected by loss of Dynactin1a. a) Putative synapses are visualized
with rab3-dendra2 labeling in single CaP cells at 2dpf. b) Distribution is
not affected, as determined by number, average area and total area, of
putative synapses. All data shown as average +/− SD (b: n cells = 26,20).
(TIF 12772 kb)
Additional file 8: Figure S8. N-Cadherin localization is not altered at
mokm632−/− adherens junctions of the NMJ. a) Confocal projection of live
2dpf Tg(cdh2:Cdh2-GFP; mokm632; mnx1:Gal4) embryos showing N-
Cadherin-GFP located at the center of a CaP NMJ synapse, determined
by presence of post-synaptic AChR labelled with conjugated α-
bungarotoxin (bath application, in red). b) Whole-mount immunohisto-
chemistry of 6dpf Tg(cdh2:Cdh2-GFP; mokm632; mnx1:Gal4) larvae show-
ing N-Cadherin-GFP (anti-GFP, in green) located at the center of an NMJ
synapse, which was co-labeled to show pre-and postsynaptic structures
(respectively, synaptotagmin2 in red and conjugated α-bungarotoxin in
blue). Boxes show close-up of the synaptic structures, surrounding the N-
Cadherin puncta. (TIF 40868 kb)
Additional file 9: Figure S9. Loss of Dynactin1a leads to abnormal
physiological properties of the NMJ. Additional metrics of NMJ whole-cell
recordings showing no change in a) Tau decay and b) rise time of 6dpf
mEPC recordings in mokm632−/− larvae. c) Additional frequencies for
paired-recordings of CaP-fast twitch muscle fibers at 6dpf showing similar
failure rates of mutant NMJs. (TIF 18204 kb)
Additional file 10: Figure S10. Overexpression of human wild-type
DCTN1 does not affect initial development of CaP motor neurons and ex-
ogenous expression is confirmed by increase in GFP signal. a) Overexpres-
sion of human wild-type DCTN1-GFP (heatmap), along with a membrane-
bound reporter (tagRFP-Caax, traced in green), is obtained in a cell-
autonomous manner and does not accumulate at synapses. b) Overex-
pression does not affect initial growth of CaP motor neurons in either
mutant embryos or their wild-type siblings at 2dpf, as determined by
total projection number, total cell length and average projection length.
c) DCTN1-GFP RNA expression is confirmed by GFP detection in 2dpf em-
bryos by fluorescent microscopy in the 488 nm channel, image shown
here for non-injected embryos with red bar for histogram generation.
Quantification confirms higher fluorescent signal in injected (400 ng/ul
DCTN1-GFP) vs non injected wild-type embryos. All data shown as aver-
age +/− SD (b: n = 8,14; c: n = 10,5) (TIF 27508 kb)
Abbreviations
AChR: Acetylcholine receptors; ALS: Amyotrophic lateral sclerosis; AZ: Active
zone; CaP: Caudal primary; DCTN1: Dynactin subunit 1; dpf: Days post-
fertilization; hpf: Hours post-fertilization; mEPCs: Miniature end plate currents;
mokm632: mikre oko m632; NMJ: Neuromuscular junction; TEER: Touch-evoked
escape response
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